Britain is a pawn in Pfizer's AstraZeneca tax game

Pfizer’s AstraZeneca bid frames Britain as little more than a convenient tax haven, and there are no guarantees the US pharma giant’s presence will benefit the public.

Pfizer, the American drug company that makes the potency pill Viagra, wants to boost its own performance by taking over AstraZeneca, a jointly owned British and Swedish company with a good record of discovering and patenting new medicinal drugs. Pfizer has already offered £63 billion ($114.623b) and, if the deal does go through, it will be the biggest ever foreign takeover of a British company.


SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles